Evaluating the cost-effectiveness of respiratory syncytial virus vaccination among risk-stratified older adults
David W. Hutton, Lisa A. Prosser, Ismael R. Ortega‐Sanchez, Andrew J. Leidner et autres
0 citationsVaccine
Mila M. Prill
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
80Publications signalées
8011Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Respiratory viral infections researchInfluenza Virus Research StudiesPneumonia and Respiratory InfectionsViral gastroenteritis research and epidemiologyCOVID-19 Clinical Research Studies
Publications récentes
RSV-Associated Hospitalizations among American Indian and Alaska Native Children in Alaska and the Southwest United States, 2019-2023
Rachel M. Hartman, Catherine G. Sutcliffe, James Keck, Jessica E. Atwell et autres
0 citationsJournal of the Pediatric Infectious Diseases Society
Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023–2024: Erratum
Laura L. Hammitt, Joel S. Espinoza, James W. Keck, Rachel M. Hartman et autres
0 citationsThe Pediatric Infectious Disease Journal
Respiratory Virus Activity — United States, July 1, 2024–June 30, 2025
Benjamin J. Silk, Mila M. Prill, Amber K. Winn, Monica E. Patton et autres
11 citationsMMWR Morbidity and Mortality Weekly Report
105. Burden and Epidemiology of Human Metapneumovirus (hMPV) Acute Respiratory Infection (ARI) among American Indian and Alaska Native (AI/AN) Children <5 years of Age, November 2019-May 2024
Rachel Hartman, Sainimere Boladuadua, Catherine Sutcliffe, James Keck et autres
0 citationsOpen Forum Infectious Diseases
P-1468. Respiratory Syncytial Virus (RSV) prevention product effectiveness against RSV-associated medically attended illness among American Indian and Alaska Native (AI/AN) children in Alaska and the Southwest United States (US), November 2023 – February 2025
Laura Hammitt, Joel Espinoza, James Keck, Rachel Hartman et autres
0 citationsOpen Forum Infectious Diseases
Nirsevimab is Effective Against Respiratory Syncytial Virus-Associated Hospitalization Among American Indian and Alaska Native Children in Their First and Second RSV Seasons in Alaska and the Southwest United States, 2023–2024
Laura L. Hammitt, James W. Keck, Rachel M. Hartman, Gilberto Alvarez-Colon et autres
4 citationsThe Pediatric Infectious Disease Journal
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus–Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025
Danielle Moulia, Ruth Link‐Gelles, Helen Y. Chu, Denise J. Jamieson et autres
51 citationsMMWR Morbidity and Mortality Weekly Report
Incidence Rates of COVID-19-Associated Hospitalization and Risk Factors for Severe Disease Among American Indian and Alaska Native Persons in the Southwest USA and Alaska
Chelsea S. Lutz, Catherine G. Sutcliffe, James W. Keck, Rachel M. Hartman et autres
0 citationsJournal of Racial and Ethnic Health Disparities
A framework for monitoring RSV prevention product effectiveness in the United States
Lauren E. Roper, Ruth Link‐Gelles, Diya Surie, Jennifer DeCuir et autres
6 citationsVaccine
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness
David W. Hutton, Lisa A. Prosser, Angela Rose, Kerra Mercon et autres
18 citationsPEDIATRICS
Cost-Effectiveness of Nirsevimab for Respiratory Syncytial Virus in Infants and Young Children
David W. Hutton, Lisa A. Prosser, Angela Rose, Kerra Mercon et autres
36 citationsPEDIATRICS
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.